News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Luca Nicosia: PLATO ATC4 phase II trial presented at ESTRO25
.sacrocuore.it
May 7, 2025, 03:26

Luca Nicosia: PLATO ATC4 phase II trial presented at ESTRO25

Luca Nicosia, Radiation Oncologist at the Department of Advanced Radiation Oncology at IRCCS, shared a post on X:

“PLATO ATC4 phase II trial

  •  Reduced dose for T1 T2 <4 cm achieved similar results to standard dose.
  • Reduced treatment interruption
  • optimal QoL.”

Luca Nicosia

More posts featuring ESTRO.

cancer ESTRO ESTRO25 Luca Nicosia OncoDaily Oncology
Special Coverage
Oncolibrary
Jul 10, 2025, 05:57
Press Release: Amgen's Bemarituzumab Shows Promise in Advanced Gastric Cancer
Drugs
Jul 10, 2025, 04:47
Taletrectinib (Ibtrozi) 2025 Updates: Uses in Cancer, Side effects, Dosage, Expectations and more
Oncolibrary
Jul 10, 2025, 04:47
Hormonal Therapy in Cancer: Mechanisms, Resistance and Clinical Applications in Breast and Prostate Cancer
Drugs
Jul 10, 2025, 01:19
Cisplatin in Cancer Treatment: Mechanism, Resistance, Toxicity, and Future Directions
Blog
Jul 9, 2025, 23:49
Sami Mansfield: Jumpstart July - Education plus Empowerment for Menopause After Cancer 
Blog
Jul 9, 2025, 23:47
Time to Renew Your ESO College Membership for 2026
Blog
Jul 9, 2025, 23:31
Few Days Left to Join Webinar on Nutrition’s Role in Cancer Care - SPCC
Blog
Jul 9, 2025, 23:14
New MSS colorectal cancer data presented at ESMOGI25 - Agenus
Insight
Jul 9, 2025, 23:06
Steven Rosenberg: The beginning of a new way to use immunotherapy
Blog
Jul 9, 2025, 22:41
Mariam Mailian: Feeling grateful after attending the ESMO GI Congress 2025
Blog
Jul 9, 2025, 22:10
Roland Busch: The busier the schedule, the more important the workout and discipline becomes
Blog
Jul 9, 2025, 21:45
Pierre Foidart: Honored to Receive Clinical Research Mandate from Stichting tegen Kanker - Fondation contre le Cancer